Considering that most vaccines are administrated as exogenous antigen, cross-presentation can play a major role in the initiation of CD8+ T cell responses especially against cancers and other infectious diseases caused by intracellular pathogens [5,8]. This evidence concerns the gene CD8A and cancer.